title: Contradictory actions on off-label use of prescription drugs? The FDA and CMS versus the U.S. Justice Department.
authors.forename: Frederic R
authors.initials: FR
authors.lastname: Curtiss
authors.forename: Kathleen A
authors.initials: KA
authors.lastname: Fairman
mesh_terms: D000329:Advertising / Q000331:legislation & jurisprudence; D014487:Centers for Medicare and Medicaid Services, U.S.; D004345:Drug Industry / Q000331:legislation & jurisprudence; D004348:Drug Labeling; D004335:Drug and Narcotic Control; D006801:Humans; D010818:Practice Patterns, Physicians' / Q000331:legislation & jurisprudence*; D055553:Prescription Drugs / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D055553:Prescription Drugs